COVID-19合并感染最新情况

IF 0.3 Q3 MEDICINE, GENERAL & INTERNAL

Erciyes Medical Journal Pub Date : 2022-01-01 DOI:10.14744/etd.2022.77864

E. Şeker

{"title":"COVID-19合并感染最新情况","authors":"E. Şeker","doi":"10.14744/etd.2022.77864","DOIUrl":null,"url":null,"abstract":"World Health Organization data indicate that as of April 2022, 6.2 million deaths have been reported worldwide due to coronavirus disease 2019 (COVID-19). In Turkiye, official statistics indicate some 15 million cases and a death toll of 98,660. It is important that clinicians consider the possibility of the co-occurrence of other respiratory microorganisms with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the virus that causes COVID-19, when managing treatment, particularly severe COVID-19 patients. The burden and effect of a secondary infection may be significant, especially in patients with chronic disease and advanced age. Proper attention to potential co-infections can prevent COVID-19 progression and the development of complications. Copyright ©C 2022 by Erciyes University Faculty of Medicine.","PeriodicalId":43995,"journal":{"name":"Erciyes Medical Journal","volume":"36 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Update on COVID-19 Coinfection\",\"authors\":\"E. Şeker\",\"doi\":\"10.14744/etd.2022.77864\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"World Health Organization data indicate that as of April 2022, 6.2 million deaths have been reported worldwide due to coronavirus disease 2019 (COVID-19). In Turkiye, official statistics indicate some 15 million cases and a death toll of 98,660. It is important that clinicians consider the possibility of the co-occurrence of other respiratory microorganisms with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the virus that causes COVID-19, when managing treatment, particularly severe COVID-19 patients. The burden and effect of a secondary infection may be significant, especially in patients with chronic disease and advanced age. Proper attention to potential co-infections can prevent COVID-19 progression and the development of complications. Copyright ©C 2022 by Erciyes University Faculty of Medicine.\",\"PeriodicalId\":43995,\"journal\":{\"name\":\"Erciyes Medical Journal\",\"volume\":\"36 1\",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Erciyes Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14744/etd.2022.77864\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Erciyes Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/etd.2022.77864","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

世界卫生组织的数据显示，截至2022年4月，全球因2019冠状病毒病(COVID-19)死亡的人数已达620万人。在土耳其，官方统计数字显示约有1 500万病例，死亡人数为98 660人。重要的是，临床医生在管理治疗时，特别是在重症COVID-19患者中，应考虑其他呼吸道微生物与导致COVID-19的病毒SARS-CoV-2感染共存的可能性。继发感染的负担和影响可能是显著的，特别是慢性病和高龄患者。适当关注潜在的合并感染可以预防COVID-19的进展和并发症的发生。埃尔西耶斯大学医学院版权所有©c2022。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Update on COVID-19 Coinfection

World Health Organization data indicate that as of April 2022, 6.2 million deaths have been reported worldwide due to coronavirus disease 2019 (COVID-19). In Turkiye, official statistics indicate some 15 million cases and a death toll of 98,660. It is important that clinicians consider the possibility of the co-occurrence of other respiratory microorganisms with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the virus that causes COVID-19, when managing treatment, particularly severe COVID-19 patients. The burden and effect of a secondary infection may be significant, especially in patients with chronic disease and advanced age. Proper attention to potential co-infections can prevent COVID-19 progression and the development of complications. Copyright ©C 2022 by Erciyes University Faculty of Medicine.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Erciyes Medical Journal MEDICINE, GENERAL & INTERNAL-

自引率

0.00%

发文量

审稿时长

16 weeks

期刊介绍： Erciyes Medical Journal (Erciyes Med J) is the international, peer-reviewed, open access publication of Erciyes University School of Medicine. The journal, which has been in continuous publication since 1978, is a publication published on March, June, September, and December. The publication language of the journal is English. The journal accepts clinical and experimental research articles in different fields of medicine, original case reports, letters to the editor and invited reviews for publication. Research articles and case reports on regionally frequent and specific medical topics are prioritized. Manuscripts on national and international scientific meetings and symposiums and manuscripts sharing scientific correspondence and scientific knowledge between authors and their readers are also published.